-Peter C Appelbaum Researcher Activity Profile

Research Author Detailed Information 

Peter C Appelbaum Publication Rate By Year

Peter C Appelbaum has published 18 paper(s) in 2007, 3 paper(s) in 2008, for a total of 21 research publications in total.

Peter C Pc Appelbaum Author Information

LAST NAME: appelbaum

FIRST NAME: Peter C

INITIALS: pc

AFFILIATION:

Papers

Peter C Appelbaum's Publication Record

1. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Year Published: 2007
Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA. pappelbaum@psu.edu
2. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis. Year Published: 2007
Penn State Milton S. Hershey Medical Center, Room C6833, BMR Bldg., Mailcode H036, 500 University Dr., Hershey, PA 17033, USA. kjulian@psu.edu
3. Genetic characterization of erythromycin- and methicillin-resistant community-acquired Staphylococcus aureus isolated from children in Texas. Year Published: 2007
Department of Pathology, Hershey Medical Center, Hershey, PA 17033, USA.
4. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Year Published: 2007
Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA. pappelbaum@psu.edu
5. Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents. Year Published: 2007
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA.
6. Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. Year Published: 2007
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA. pappelbaum@psu.edu.
7. Multidrug-Resistant Streptococcus pneumoniae Infections : Current and Future Therapeutic Options. Year Published: 2007
8. Genetic characterization of erythromycin- and methicillin-resistant community-acquired Staphylococcus aureus isolated from children in Texas. Year Published: 2007
Department of Pathology, Hershey Medical Center, Hershey, PA 17033, USA.
9. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Year Published: 2007
10. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Year Published: 2007
Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA. pappelbaum@psu.edu
11. Comparative Antianaerobic Activities of Doripenem Determined by MIC and Time-Kill Analysis. Year Published: 2007
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. pappelbaum@psu.edu.
12. In Vitro Activity of DC-159a, a New Broad-Spectrum Fluoroquinolone, Compared with That of Other Agents against Drug-Susceptible and -Resistant Pneumococci. Year Published: 2007
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. pappelbaum@psu.edu.
13. Subinhibitory Concentrations of Azithromycin Decrease Nontypeable Haemophilus influenzae Biofilm Formation and Diminish Established Biofilms. Year Published: 2007
Department of Pediatrics, University of Iowa, 2080H Medical Laboratories, 200 Hawkins Drive, Iowa City, IA 52242. timothy-starner@uiowa.edu.
14. Activity of Meropenem with and without Ciprofloxacin and Colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Year Published: 2007
Department of Pathology, Hershey Medical Center, Hershey, PA 17033. pappelbaum@psu.edu.
15. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis. Year Published: 2007
Penn State Milton S. Hershey Medical Center, Room C6833, BMR Bldg., Mailcode H036, 500 University Dr., Hershey, PA 17033, USA. kjulian@psu.edu
16. Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents. Year Published: 2007
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA.
17. Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. Year Published: 2007
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA. pappelbaum@psu.edu.
18. Activity of ceftobiprole compared with those of other agents against Staphylococcus aureus strains with different resistotypes by time-kill analysis. Year Published: 2008
Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA.
19. In Vitro Capability of Faropenem To Select for Resistant Mutants of Streptococcus pneumoniae and Haemophilus influenzae. Year Published: 2008
Department of Pathology, Hershey Medical Center, 500 University Drive, Hershey, PA 17033. pappelbaum@psu.edu.
20. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Year Published: 2007
Unité de Pharmacologie Cellulaire et Moléculaire, Université Catholique de Louvain, Brussels, Belgium. vanbambeke@facm.ucl.ac.be
21. In vitro capability of faropenem to select for resistant mutants of Streptococcus pneumoniae and Haemophilus influenzae. Year Published: 2008
Department of Pathology, Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA.